Skip to content
FoodEdge
News

Fungal fermentation: MATR opens a 4,000 tonne plant on EUR 40M, half of it debt

Denmark’s MATR Foods has opened its first industrial plant early, but full capacity waits until 2028, and the EIB loan behind half the funding is serviced from tonnes sold.

For Investors
A thick brown patty with red cabbage slaw in a soft white bun, cut in half and stacked on a pale blue plate.
A MATR burger made from fungal fermented vegetables. Photo: MATR Foods, press release image, via Via Ritzau.

MATR Foods opened its first industrial plant on 20 November at Skovlund, near Varde in West Jutland, earlier than the “early 2027” start its investors announced when they funded it. The money behind the build was EUR 40M, and half of it is a venture loan from the European Investment Bank. The plant can make up to 4,000 tonnes a year, but the chief executive does not expect full capacity until 2028. For whole-food fungal fermentation, building the plant was the first proof. Filling it fast enough to carry the debt is the next one.

At a glance

  • EUR 40Mraised in October 2025: EUR 20M Series A equity plus EUR 20M EIB venture debt (Novo Holdings; EIB)
  • 4,000 tonnesa year of patties, blocks and mince at full capacity (MATR release)
  • 2028the year MATR expects to reach full capacity (CEO to AgFunderNews)
  • EUR 10,000of the round per tonne of annual capacity (FoodEdge calculation)

Funding from the Novo Holdings release of 21 October 2025 and the EIB release of 12 September 2024; capacity from MATR’s release of 20 November 2026; ramp-up from AgFunderNews, 20 November 2026. Checked 21 November 2026.

According to MATR’s release, the move takes the Danish company from small-scale production in Copenhagen’s Nordhavn to an industrial site with 60 staff. MATR sells under its own brand: in Denmark through COOP, Nemlig.com, Alma and Aarstiderne, and in Germany through Rewe Online, HIT and selected REWE and Edeka stores around Hamburg. Switzerland is the third target market. Chief executive Randi Wahlsten told AgFunderNews that MATR has no plans for private label at this stage.

The plant was financed by a EUR 40M round in October 2025, co-led by Novo Holdings and the Export and Investment Fund of Denmark (EIFO): EUR 20M in Series A equity and EUR 20M in venture debt from the EIB, Novo Holdings said at the time. The EIB loan, signed in September 2024 under InvestEU, supports construction of the plant and R&D; the EIB then described a target of over 3,000 tonnes a year. Danish trade title FødevareWatch reports that the plant is planned to bring the company into profit before 2030.

The process inoculates boiled, chopped organic peas, lupins, beets, potatoes and oats with a single fungal strain. MATR says the strain is non-novel, so no novel food approval is needed, and claims its solid-state route costs less in capex and opex than submerged biomass or precision fermentation. It gave no cost figures. Wahlsten also said studies on protein and mineral bioavailability in the current product have not yet been completed.

“As this is a first of a kind technology and a big scale leap, our plan is to allow some time to ramp up. We do not expect to be at full capacity until 2028.”

Randi Wahlsten, CEO and co-founder of MATR Foods, as quoted by AgFunderNews

FoodEdge view: the plant is built, and the utilisation curve is now the bet

Our reading is that MATR has cleared the step many European alt protein companies failed at: a funded, open plant with branded listings in two countries. Half of the EUR 40M is debt, though, and debt is serviced from tonnes sold. With about EUR 10,000 raised per tonne of annual capacity, each year spent well below full use loads more fixed cost onto every kilo. Skipping novel food approval removes a delay; the volume risk stays.

The due diligence question: how many of the 4,000 tonnes are contracted for 2027, what does a kilo cost at that volume, and when do EIB repayments start?

Weighing a food biotech or nutrition deal? Independent technical due diligence, before you sign.

How we checked

  1. Sources: MATR release on CSR.dk, 20 Nov 2026; Novo Holdings release, 21 Oct 2025; EIB release, 12 Sep 2024; AgFunderNews, 20 Nov 2026; FødevareWatch, 20 Nov 2026 (headline and summary only, paywalled).
  2. Snapshot: 21 November 2026. All amounts were published in euros.
  3. Key assumption: EUR 10,000 per tonne divides the whole EUR 40M round by 4,000 tonnes of annual capacity. Part of the round also funds R&D and sales abroad, so the plant-only figure is lower. Counting only the EUR 20M EIB loan, it is EUR 5,000 per tonne.
  4. Main limit: MATR has not disclosed plant capex, contracted volumes, prices, unit costs or loan terms. Its cost advantage over other fermentation routes is a company claim. FoodEdge did not review MATR’s annual accounts.

AI tools supported source research and drafting during the editorial process.

DiscussionOpenClose

More to explore

All publications